宋淑亮 简历
云顶yd222线路检测,博士、高级实验师、硕士生导师
邮箱:songshuliang@sdu.edu.cn
男,云顶yd222线路检测高级实验师、硕士生导师。主持山东省自然科学基金3项、市科技攻关项目1项、横向课题多项;作为主要参与人参与国家自然科学基金3项、省部级基金5项、地市及横向课题12项。目前主要从事海洋生物资源综合利用、心血管药理学等研究。目前以第一作者或通讯作者发表论文36篇,其中SCI论文26篇,已申请发明专利30项,其中授权发明专利26项,国际专利2项,转让专利7项。
教育经历:
1.2017/03–2023/06, 云顶yd222线路检测, 微生物学, 博士, 导师:陈冠军
2.2003/09–2006/06, 云顶yd222线路检测, 微生物与生化药学,硕士,导师:吉爱国
3.1999/08–2003/06, 云顶yd222线路检测, 药学, 学士, 导师:吉爱国
科研与学术工作经历:
1.2014/09-至今, 云顶yd222线路检测,威海校区,高级实验师
2.2008/10-2014/08,云顶yd222线路检测,威海校区,实验师
3.2006/07-2008/09,云顶yd222线路检测,威海校区,助理实验师
主持或参加科研项目(课题)及人才计划项目情况:
1、山东省自然科学基金面上项目,ZR2022MH279,岩藻聚糖通过TFEB调控泡沫细胞自噬的作用途径及其作用机制研究,2023/01-2025/12,10万元,在研,主持。
2、山东省自然科学基金面上项目,ZR2017MH040,水蛭肽抑制动脉粥样硬化中巨噬细胞迁移的信号通路和作用靶点的研究,2017/08-2020/06,14万元,已结题,主持。
3、山东省自然科学基金培养项目,ZR2015PH050,水蛭活性肽对动脉粥样硬化中血管平滑肌细胞的药理作用及其机制研究,2015/07-2017/12,4万元,已结题,主持。
4、一种预防病毒传染的复方制剂及其配制/使用方法与应用,2023/02,5万元,在研,主持。
5、一种海肠胶及其制备方法和应用、一种羊栖菜多糖提取液及其制备方法和应用专利转让,2022/08,14万元,已结题,主持。
6、一种润肠通便的速食粥及其制备方法和应用(专利转让),2021/10,5万元,已结题,主持。
7、多种海洋活性物质初步筛选开发及应用,2021/08-2022/08,20万元,在研,主持
8、海参脂溶性提取物、及含该提取物的唇膏及制备方法(专利转让),2020/04,3万元,已结题,主持。
9、一种海星酶解提取物及其制备方法和应用(专利转让),2019/10,3万元,已结题,主持。
10、一种面膜的制备方法(专利转让),2019/05,5万元,已结题,主持。
11、一种海参肽稳定制剂及其制备方法与应用(专利转让),2016/04-2017/06,20万元,已结题,主持。
12、威海市科技攻关项目,威海海参资源深加工产品开发的研究,2013/12-2016/12,10万元,已结题,主持。
13、国家自然科学基金面上项目,82273992,Pellino1调控细胞衰老促慢性阻塞性肺疾病的作用机制及其化学干预, 2023/01-2026/12,52万元,在研,参加(2/8)。
14、山东省自然科学基金面上项目,ZR2019MH001,E3泛素连接酶Pellino1及其天然新抑制剂Resistomycin调控乳腺癌EMT和侵袭转移的机制,2019/07-2022/06,20万元,已结题,参与(3/8)。
15、山东省自然科学基金博士基金,ZR2019BC053,多尺度双网络凝胶搭载益生菌体系的构建及传质规律研究,2019/07-2022/06,10万元,已结题,参与(2/5)。
16、山东省自然科学基金培养项目,ZR2017PH053,基于肠道微生物探究刺参多糖抗2型糖尿病作用及机制,2017/07-2018/12,4万元,已结题,参加(2/6)。
17、山东省自然科学基金培养项目,ZR2017PC009,氧化淀粉介导鱼明胶复合可食用膜的设计及机理研究,2017/07-2018/12,4万元,已结题,参加(3/5)。
18、国家自然科学基金面上项目,81371455,岩藻糖基化海参硫酸软骨素促进神经干细胞向脑损伤部位迁移的作用及其机制研究, 2014/01-2017/12,70万元,已结题,参加(2/10)。
19、威海市重大科技专项,2013ZD004,海藻健康产品技术创新平台,2014/01-2016/12,200万元,已结题,参加(2/6)。
20、国家自然科学基金面上项目,30873198,刺参岩藻多糖对神经前体细胞增殖的作用及其机制研究,2009/01-2011/12,34万元,已结题,参加(2/10)。
代表性研究成果和学术奖励情况
一、期刊论文
(1)Yan Wang, Xiao Zhang, Xiao Tian, Yuan Wang, Xiang Xing*, and Shuliang Song*. Research progress on the functions, preparation and detection methods of
L-fucose[J]. Food Chemistry, 2024, 433:137393.(JCR一区;中科院一区; Top期刊)
(2)E Zhang, Chuangeng Shang, Mingtao Ma, Xuanfeng Zhang, Yu Liu, Shuliang Song*, and Xia Li*. Polyguluronic acid alleviates doxorubicin-induced cardiotoxicity by suppressing Peli1-NLRP3 inflammasome-mediated pyroptosis[J]. Carbohydrate Polymers, 2023, 321:121334.(JCR一区;中科院一区; Top期刊;IF:11.2)
(3)Xu Yiwei, Hao Xiaodong, Ren Yidan, Xu Qinchen, Liu Xiaoyan, Song Shuliang*, and Wang Yunshan*. Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma. FRONTIERS IN ONCOLOGY. 2023; 12: 1063423(JCR二区)
(4)Song, Shuliang, Qiang Wei, Ke Wang, Qiong Yang, Yu Wang, Aiguo Ji*, and Guanjun Chen*. Fluorescent labeling of polymannuronic acid and its distribution in mice by tail vein injection. Marine Drugs. 2022; 20: 289. (JCR一区)
(5)Wei, Qiang, Guoqiang Fu, Ke Wang, Qiong Yang, Jiarui Zhao, Yuan Wang, Kai Ji*, Shuliang Song*. Advances in Research on Antiviral Activities of Sulfated Polysaccharides from Seaweeds. Pharmaceuticals. 2022; 15: 581. (JCR一区)
(6)Ke Wang#, Qi Cao#, Qiong Yang, Qiang Wei, Jiarui Zhao, Yuan Wang, Junfeng Hou*, Shuliang Song*. Study on the regulatory effect of leech peptide HE-D on macrophages in atherosclerosis by transcriptome sequencing. Journal of Ethnopharmacology. 2022; 294: 115380. (JCR一区;中科院一区; Top期刊)
(7)Qiang Wei#, Maochen Xing#, Ke Wang, Qiong Yang, Jiarui Zhao, Yuan Wang, Xia Li, Kai Ji* and Shuliang Song*. Fucoidan Is Not Completely Dependent on Degradation to Fucose to Relieve Ulcerative Colitis. Pharmaceuticals. 2022; 15(4):430. (JCR一区)
(8)Qiong Yang#, Maochen Xing#, Ke Wang, Qiang Wei, Jiarui Zhao, Yuan Wang, Kai Ji* and Shuliang Song*. Application of Fucoidan in Caco-2 Model Establishment. Pharmaceuticals. 2022; 15(4):418. (JCR一区)
(9)Ke Wang, Xueli Xu, Qiang Wei, Qiong Yang, Jiarui Zhao, Yuan Wang, Xia Li, Kai Ji* and Shuliang Song*. Application of fucoidan as treatment for cardiovascular and cerebrovascular diseases [J]. Therapeutic Advances in Chronic Disease, 2022, 13:1-15.(JCR一区)
(10)Jiarui Zhao#, Bo Hu#, Han Xiao, Qiong Yang, Qi Cao, Xia Li, Qian Zhang, Aiguo Ji* and Shuliang Song*. Fucoidan reduces lipid accumulation by promoting foam cell autophagy via TFEB [J]. Carbohydrate Polymers, 2021, 268:118247.(JCR一区;中科院一区; Top期刊;IF:9.381)
(11)Han Xiao, Jiarui Zhao, Chang Fang, Qi Cao, Maochen Xing, Xia Li, Junfeng Hou, Aiguo Ji* and Shuliang Song*. Advances in Studies on the Pharmacological Activities of Fucoxanthin [J]. Marine drugs, 2020, 18:634. (JCR一区)
(12)Qi Cao, Jiarui Zhao, Maochen Xing, Han Xiao, Qian Zhang, Hao Liang, Aiguo Ji* and Shuliang Song*. Current Research Landscape of Marine-Derived Anti-Atherosclerotic Substances[J]. Marine drugs, 2020, 18:440. (JCR一区)
(13)Jiarui Zhao, Qi Cao, Maochen Xing, Han Xiao, Zeyu Cheng, Shuliang Song* and Aiguo Ji*. Advances in the Study of Marine Products with Lipid-Lowering Properties[J]. Marine drugs, 2020, 18:390. (JCR一区)
(14)Yu Wang, Xu Bai, Bo Hu, Maochen Xing, Qi Cao, Aiguo Ji, Shuliang Song*. Transport Mechanisms of Polymannuronic Acid and Polyguluronic Acid Across Caco-2 Cell Monolayers[J]. Pharmaceutics, 2020, 12(2):167. (JCR一区)
(15)Maochen Xing, Qi Cao, Yu Wang, Han Xiao, Jiarui Zhao, Qing Zhang, Aiguo Ji, Shuliang Song*. Advances in Research on the Bioactivity of Alginate Oligosaccharides[J]. Marine drugs, 2020, 18(3):144. (JCR一区)
(16)Xu Bai#, E Zhang#, Bo Hu, Hao Liang, Shuliang Song* and Aiguo Ji*. Study on Absorption Mechanism and Tissue Distribution of Fucoidan[J]. Molecules, 2020, 25(5):1087. (JCR二区)
(17)Xu Bai, Yu Wang, Bo Hu, Qi Cao, Maochen Xing, Shuliang Song*, Aiguo Ji*. Fucoidan Induces Apoptosis of HT-29 Cells via the Activation of DR4 and Mitochondrial Pathway[J]. Marine drugs, 2020, 18:220. (JCR一区)
(18)Bo Hu, Lixu Xu, Ying Li, Xu Bai, Maochen Xing, Qi Cao, Hao Liang, Shuliang Song∗, Aiguo Ji∗. A peptide inhibitor of macrophage migration in atherosclerosis purified from the leech Whitmania pigra[J]. Journal of Ethnopharmacology, 2020, 254:112723. (JCR一区;中科院一区; Top期刊)
(19)Wang Yu, Xing Maochen, Cao Qi, Ji Aiguo, Liang Hao, Song Shuliang*. Biological Activities of Fucoidan and the Factors Mediating Its Therapeutic Effects: A Review of Recent Studies[J]. Marine drugs, 2019, 17(3):183.(JCR一区)2020年、2021年高被引论文
(20)Lixu Xu, Xue Li, E Zhang, Hao Liang, Weiting Li, Shangyi Wang, Shuliang Song*, Aiguo Ji. The effect of leech extracts on endothelial cell coagulation-related factors and endothelial dysfuction-related molecules[J]. Clinical and Experimental Hypertension, 2019, 41(3):220-230. (JCR四区)
(21)E Zhang#, Fulong Chu#, Lixu Xu, Hao Liang, Shuliang Song*, Aiguo Ji*. Use of fluorescein isothiocyanate isomer I to Study the Mechanism of Intestinal Absorption of Fucoidan Sulfate In vivo and In vitro[J]. Biopharmaceutics and Drug Disposition, 2018, 39(6):298-307. (JCR四区)
(22)Liu C M, Chen X T, Pan Y Y, Liang H, Song S L*, Ji A G*. Antitumor Studies of Earthworm Fibrinolytic Enzyme Component A from Eisenia foetida on Breast Cancer Cell Line MCF-7[J]. Indian Journal of Pharmaceutical Sciences, 2017, 79(3):361-368. (JCR四区)
(23)Li X, Yang L, Wang YS, Liang H, Song SL*, Ji AG*. Fucoidan Induce Apoptosis of HeLa Cells Accompanied by The Induction of Autophagy[J]. Latin American Journal of Pharmacy, 2017, 36(6):1126-1133. (JCR四区)
(24)Shuaishuai Li, Long Cheng, Dengkun An, Shuliang Song*, Hao Liang, Fulong Chu, Aiguo Ji. Whitmania pigra Whitman extracts inhibit lipopolysaccharide induced rat vascular smooth muscle cells migration and attenuate their adhesion ability to THP-1 and RAW 264.7 cells[J]. Journal of Atherosclerosis and Thrombosis, 2017, 24:301-311. (JCR一区)
(25)Fulong Chu#, Xiaochen Wang#, Qianqian Sun, Hao Liang, Sijian Wang, Dengkun An, Chao Cui, Yuchao Chai, Shuaishuai Li, Shuliang Song*, Aiguo Ji*. Purification and characterization of a novel fibrinolytic enzyme from Whitmania pigra Whitman[J]. Clinical and Experimental Hypertension, 2016, 38(7):594-601. (JCR四区)
(26)Shuliang Song#, Yuling Wang#, Kai Ji, Hao Liang, Aiguo Ji*. Effect of earthworm active protein on fibroblast proliferation and its mechanism[J]. Pharmaceutical Biology, 2016, 54(4):732-739. (JCR一区)
(27)Shuliang, Song,Lei, Cui,Guangwu, Jing,Changjie, Liu*,Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells[J]. Oncology Research,2013,21(3):121-127.(JCR二区)
(28)王媛,赵佳锐,魏强,王珂,杨琼,吉爱国,宋淑亮*. 一种新型海带面膜的制作工艺及检测[J]. 香料香精化妆品,2023,(3):53-56,81.
(29)程泽宇, 赵佳锐, 肖翰, 谷美华, 吉爱国, 宋淑亮*.单环刺螠的活性成分及其在调味品开发中的应用研究进展[J].食品科技, 2020, 45(04):253-258.
(30)师盼,林重华,舒易方,瞿家权,宋淑亮*. 柠檬酸转运体SLC25A1对食管鳞癌细胞体外放射敏感性的影响及其分子机制[J]. 癌变·畸变·突变,2020,432(2): 132-138.
(31)于文静,师盼,潘琼,柴进,宋淑亮*. 胆汁淤积下FGF19-ERK通路可上调MRP3/4表达减轻肝细胞损伤[J]. 中国细胞生物学学报,2019,41(8): 1588-1594.
(32)王宇, 张健, 姜进举, 邢茂辰,曹琪,梁浩,吉爱国,宋淑亮*. 天然活性多糖口服吸收研究进展[J]. 生命的化学, 2019, 39(3): 605-610.
(33)王凯玥,张娥,梁浩,吉爱国,宋淑亮*. 一种不沾杯唇膏的配方设计及其性质检测[J]. 香料香精化妆品,2019,(1):47-50.
(34)乔新宇,白相敏,吴美瑶,郑玲燕,宋淑亮*. 甘草粉美白面膜的制作工艺研究[J]. 香料香精化妆品,2019,(2):40-44.
(35)宋淑亮, 王欢, 梁浩, 吉爱国*. 海参肽的分离纯化及其对NIH/3T3细胞胶原蛋白分泌的影响[J]. 现代食品科技, 2017,(3):28-34.
(36)安杨, 柴玉超, 赵统德, 宋淑亮*,吉爱国. 羊栖菜多糖的提取及其在化妆品中的应用[J]. 香料香精化妆品, 2017,(1):58-61.
(37)柴玉超,刘云,姜新旭,程慧玲,宋淑亮*,吉爱国. 海参肽对成纤维细胞的作用及与其他抗皱成分的比较[J]. 香料香精化妆品, 2015,(6):51-55.
二、国际发明专利:
(1)吉爱国,宋淑亮,一种水蛭肽及其应用,2022.11.22,美国,US11505580B2
(2)吉爱国,宋淑亮,一种水蛭肽及其应用,2022.06.24,日本,特许第7097037号
(3)宋淑亮,吉爱国,一种预防病毒传染的复方制剂及其配制/使用方法与应用,2021.1.13,PCT/CN2021/071507(有新颖性)(韩国:KR1020237008289)
(4)宋淑亮,吉爱国,张娥,一种海藻面膜及其制备方法和应用,2020.6.3,PCT/CN2020/094108(有新颖性)
三、授权发明专利:
(1)吉恺,宋淑亮,单环刺螠浸出液蛋白质提取物及其提取方法与应用,2023.07.28,中国,202110858778.6
(2)宋淑亮,陈锚,潘炳旗,王珂,杨琼,关浩,马士玉,张新峰,多肽在调控成纤维细胞体外培养中的应用,2023.04.28,中国,202111168263.X
(3)吉恺,宋淑亮,一种硫酸多糖抗病毒层及其制备方法及抗病毒口罩,2023.04.11,中国,202010908961.8
(4)宋淑亮,吉爱国,一种预防病毒传染的复方制剂及其配制/使用方法与应用,2022.08.02,中国,202010857170.7(已转让)
(5) 宋淑亮,吉爱国,海参多肽及其应用,2022.07.29,中国,201910414495.5
(6)宋淑亮,吉爱国,赵佳锐,李霞,程泽宇,刘家齐,一种海肠胶及其制备方法和应用,2022.07.29,中国,202110571177.7(已转让)
(7)宋淑亮,吉爱国,一种具有抑制巨噬细胞增殖活性的海参多肽及其应用,2022.07.15,中国,201910412343.1
(8)宋淑亮,吉爱国,酪胺-岩藻聚糖在预防病毒经黏膜传播中的应用及其制备方法、药剂,2022.05.17,中国,202010790345.7
(9)吉爱国,宋淑亮,一种水蛭肽及其应用,2022.02.15,中国,201910394108.6
(10) 宋淑亮,陈锚,潘炳旗,王珂,马士玉,关浩,陈晓东,尹宪利,多肽在调控巨噬细胞体外转型中的应用,2022.01.18,中国,202111316820.8
(11) 宋淑亮,陈锚,魏强,尹宪利,马士玉,关浩,刘云飞,何娟,可降解海藻膜及其制备方法和包装制品,2021.12.31,中国,202111104054.9
(12) 宋淑亮,陈锚,王珂,赵延霞,马士玉,刘云飞,水蛭肽HE-D在护肤美白中的应用,2021.12.21,中国,202111090304.8
(13) 宋淑亮,吉爱国,张娥,一种海藻面膜及其制备方法和应用,2021.09.28,中国,202010334282.4
(14)宋淑亮,吉爱国,张娥,一种黄瓜面膜及其制备方法,2021.07.02,中国,202010333102.0
(15)宋淑亮,曹琪,邢茂辰,吉爱国,一种海藻糖栓剂及其制备方法和应用,2021.06.25,中国,201910020975.3
(16)宋淑亮,吉爱国,岩藻聚糖硫酸酯在促进泡沫细胞自噬分解ox-LDL中的应用,2021.03.19,中国,202010071273.0
(17)宋淑亮,张娥,王宇,吉爱国,一种酸性多糖电泳标准品及其制备方法和应用,2020.6.30,中国,201910486681.X
(18)宋淑亮,吉爱国,张娥,一种从海带加工废液中提取岩藻聚糖硫酸酯的新工艺,2020.3.27,中国,201710730736.8
(19)宋淑亮,王宇,张娥,吉爱国,扇贝边美白肽的制备方法和应用,2019.10.11,中国,201710942870.4
(20) 宋淑亮,吉爱国,一种羊栖菜多糖提取液及其制备方法和应用,2019.4.30,中国,201610286472.7(已转让)
(21)宋淑亮,张娥,吉爱国,一种面膜的制备方法,2019.2.26,中国,201610584405.3(已转让)
(22)宋淑亮,吉爱国,成龙,一种水蛭多肽的分离纯化方法,2018.10.26,中国,201610040895.0(已转让)
(23)宋淑亮,张娥,吉爱国,海参脂溶性提取物、及含该提取物的唇膏及制备方法,2018.8.28,中国,201610428110.7(已转让)
(24)宋淑亮,吉爱国,一种药食两用海参肽组合物、制备方法及其应用,2017.8.22,中国,201510624206.6
(25)宋淑亮,吉爱国,一种海星酶解提取物及其制备方法和应用,2017.5.3,中国,ZL201510120730.X(已转让)
(26)宋淑亮,张娥,一种海参肽稳定制剂及其制备方法与应用,2016.2.29,中国,ZL201410135479.X(已转让)
四、获奖:
(1)2021年云顶yd222线路检测实验室工作先进个人,2022.08,云顶yd222线路检测,1/1
(2)2019-2020学年优秀本科生导师,2020.06,云顶yd222线路检测(威海),1/1
(3)2018年山东省优秀学士学位论文指导教师,2018.11.18,山东省教育厅,2/2